homovanillic acid has been researched along with Dementia in 60 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebrospinal fluid (CSF) concentration of beta-endorphin (beta-Ep), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) was measured in 15 patients with dementia of the Alzheimer type (DAT) and in 16 patients suspected of having Binswanger's disease (BD) by MRI, which sometimes resembles DAT clinically." | 7.68 | CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly. ( Chiba, T; Hagiwara, M; Kaieda, R; Kitahama, T; Lee, S; Nagazumi, A; Terashi, A, 1990) |
| "In a single-blind study, 12 men (mean age 63 years) with senile dementia were given nafronyl in a dosage of 100 mg eight times daily for a week, followed by 100 mg four times daily for 12 weeks." | 7.66 | Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia. ( Berger, PA; Hollister, LE; Tinklenberg, JR; Yesavage, JA, 1982) |
| "It is concluded that in severe forms of senile dementia of Alzheimer type, there is a decrease in the levels of HVA and 5-HIAA in CSF which may reflect a decreased turnover of dopamine and serotonin." | 5.26 | Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. ( MacDonald, E; Rekonen, M; Riekkinen, PJ; Soininen, H, 1981) |
| "Cerebrospinal fluid (CSF) concentrations of somatostatin-like immunoreactivity (SLI), high molecular weight form somatostatin (HMV-SST), somatostatin-25/28 (SST-25/28), somatostatin-14 (SST-14), Des-ala-somatostatin (Des-ala-SST), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were measured in 21 patients with Binswanger's dementia (BD)." | 3.69 | Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations. ( Cramer, H; Grauer, MT; Hamann, GF; Schimrigk, K; Strittmatter, M, 1996) |
| "Cerebrospinal fluid (CSF) concentration of beta-endorphin (beta-Ep), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) was measured in 15 patients with dementia of the Alzheimer type (DAT) and in 16 patients suspected of having Binswanger's disease (BD) by MRI, which sometimes resembles DAT clinically." | 3.68 | CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly. ( Chiba, T; Hagiwara, M; Kaieda, R; Kitahama, T; Lee, S; Nagazumi, A; Terashi, A, 1990) |
| "Changes in the activity of neurotransmitters in dementia were studied by measuring the activities of each of choline acetyltransferase (CAT), dopamine-beta-hydroxylase (DBH) and hydroxylase cofactor (tetrahydrobiopterine; BPH4), and the concentrations of homovanillic acid (HVA) and vasopressin." | 3.67 | Neurotransmitters in dementia. ( Fujiyoshi, K; Iijima, S; Kato, T; Koshimura, K; Miyata, S; Nagata, H; Nakamura, S; Okamoto, K; Suga, H; Yamao, S, 1984) |
| " We tested patients with PD, patients with Alzheimer's type of senile dementia, and a control group neuropsychologically, and we determined their CSF levels of homovanillic acid, 3,4-dihydroxyphenylacetic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindolacetic acid, serotonin, and acetylcholinesterase." | 3.67 | Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings. ( Albert, ML; Direnfeld, LK; Kaplan, E; Langlais, PJ; Marquis, J; Volicer, L, 1984) |
| "Effects of indeloxazine, a new compound which has been though to block reuptake of serotonin and noradrenaline, on cerebrospinal fluid monoamine metabolites were evaluated in 11 patients with dementia." | 3.67 | Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites. ( Fukuzawa, N; Mizuno, Y; Shimabukuro, T, 1988) |
| "Mean levels of the two hydrolases angiotensin-converting enzyme (ACE) and acetylcholinesterase (AChE), the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), and total protein concentration were examined in cerebrospinal fluid (CSF) samples from a group of patients with dementia of the Alzheimer's type, a group of comparably demented patients with Parkinson's disease, and a neurologically healthy elderly control group." | 3.67 | Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. ( Direnfeld, LK; Langlais, PJ; Marquis, JK; Nixon, RA; Volicer, L; Zubenko, GS, 1986) |
| "Probenecid was administered to 7 unipolar depressed patients, 7 parkinsonians and 7 extrapyramidal patients with senile dementia matched for age and sex." | 3.66 | Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method. ( Mendlewicz, J; Noel, G; Vanderheyden, JE, 1981) |
| "In a single-blind study, 12 men (mean age 63 years) with senile dementia were given nafronyl in a dosage of 100 mg eight times daily for a week, followed by 100 mg four times daily for 12 weeks." | 3.66 | Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia. ( Berger, PA; Hollister, LE; Tinklenberg, JR; Yesavage, JA, 1982) |
| "Noradrenaline, dopamine, homovanillic acid (HVA), choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) levels were measured in post-mortem brains from 8 cases of pre-senile Alzheimer-type dementia (ATD), 5 cases of senile ATD, 4 cases of Down's syndrome aged 53-57 years, one 27-year-old case of Down's syndrome and 13 controls." | 3.66 | Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. ( Allison, Y; Gordon, A; Maloney, AF; Ritchie, IM; Simpson, J; Urquhart, A; Yates, CM, 1983) |
| "Abnormalities found in senile or presenile dementia were not always parallel to the age-related changes." | 2.38 | Senile dementia and presenile dementia. ( Nakamura, S, 1990) |
| "Subjects with Alzheimer type dementia (AD), vascular dementia (VD), and controls without dementia (C) were investigated." | 1.30 | Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. ( Wada, H, 1998) |
| "Distinguishing Alzheimer's disease from DLB is clinically relevant in terms of prognosis and appropriate treatment." | 1.30 | Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. ( Ballard, C; Burn, D; Court, JA; Jaros, E; Johnson, M; Lloyd, S; Marshall, EF; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA; Thomas, N, 1999) |
| "There is some evidence that Parkinson's disease (PD) seems to be a heterogenous and generalized brain disorder reflecting a degeneration of multiple neuronal networks, including somatostatinergic neurons." | 1.29 | Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa. ( Cramer, H; Hamann, GF; Schimrigk, K; Strittmatter, M; Strubel, D, 1996) |
| "Patients who had Alzheimer's disease-senile dementia of the Alzheimer type (AD/SDAT) or multi-infarct dementia (MID) were compared with a group of controls." | 1.27 | Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems. ( Adolfsson, R; Bucht, G; Winblad, B, 1984) |
| "The Rett syndrome is a progressive disorder in female patients that is characterized by autistic behavior, dementia, ataxia, loss of purposeful use of the hands, and seizures." | 1.27 | Reduction of biogenic amine levels in the Rett syndrome. ( Butler, IJ; Glaze, DG; Percy, AK; Riccardi, VM; Zoghbi, HY, 1985) |
| "In patients with Parkinson's disease the levels of somatostatin-like immunoreactivity were lower than in the controls (p less than 0." | 1.27 | Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. ( Halonen, T; Jolkkonen, J; Laakso, M; Laulumaa, V; Riekkinen, P; Soininen, H; Ylinen, A, 1986) |
| "It is concluded that in severe forms of senile dementia of Alzheimer type, there is a decrease in the levels of HVA and 5-HIAA in CSF which may reflect a decreased turnover of dopamine and serotonin." | 1.26 | Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. ( MacDonald, E; Rekonen, M; Riekkinen, PJ; Soininen, H, 1981) |
| "The diagnosis of Alzheimer's disease (13 patients) and Pick's disease (4 patients) has been made on clinical and radiological grounds." | 1.26 | [Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid]. ( Chazot, G; Guard, O; Renaud, B, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (73.33) | 18.7374 |
| 1990's | 15 (25.00) | 18.2507 |
| 2000's | 1 (1.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelborghs, S | 1 |
| Vloeberghs, E | 1 |
| Maertens, K | 1 |
| Marescau, B | 1 |
| De Deyn, PP | 1 |
| Mayeux, R | 1 |
| Nakamura, S | 4 |
| Koshimura, K | 1 |
| Kato, T | 1 |
| Yamao, S | 2 |
| Iijima, S | 1 |
| Nagata, H | 1 |
| Miyata, S | 1 |
| Fujiyoshi, K | 1 |
| Okamoto, K | 1 |
| Suga, H | 1 |
| Carlsson, A | 1 |
| Adolfsson, R | 5 |
| Aquilonius, SM | 1 |
| Gottfries, CG | 6 |
| Oreland, L | 1 |
| Svennerholm, L | 1 |
| Winblad, B | 4 |
| Argentiero, V | 1 |
| Tavolato, B | 1 |
| Vanderheyden, JE | 1 |
| Noel, G | 1 |
| Mendlewicz, J | 1 |
| Soininen, H | 2 |
| MacDonald, E | 1 |
| Rekonen, M | 1 |
| Riekkinen, PJ | 1 |
| Yesavage, JA | 1 |
| Tinklenberg, JR | 1 |
| Hollister, LE | 1 |
| Berger, PA | 2 |
| Bareggi, SR | 1 |
| Franceschi, M | 1 |
| Bonini, L | 1 |
| Zecca, L | 1 |
| Smirne, S | 1 |
| Wood, PL | 1 |
| Etienne, P | 1 |
| Lal, S | 1 |
| Gauthier, S | 1 |
| Cajal, S | 1 |
| Nair, NP | 1 |
| Bucht, G | 1 |
| Yates, CM | 1 |
| Simpson, J | 1 |
| Gordon, A | 1 |
| Maloney, AF | 1 |
| Allison, Y | 1 |
| Ritchie, IM | 1 |
| Urquhart, A | 1 |
| Cross, AJ | 1 |
| Crow, TJ | 1 |
| Ferrier, IN | 1 |
| Johnson, JA | 1 |
| Markakis, D | 1 |
| Direnfeld, LK | 2 |
| Albert, ML | 1 |
| Volicer, L | 2 |
| Langlais, PJ | 2 |
| Marquis, J | 1 |
| Kaplan, E | 1 |
| Zimmer, R | 1 |
| Teelken, AW | 1 |
| Trieling, WB | 1 |
| Weber, W | 1 |
| Weihmayr, T | 1 |
| Lauter, H | 1 |
| Mann, JJ | 1 |
| Stanley, M | 1 |
| Neophytides, A | 1 |
| de Leon, MJ | 1 |
| Ferris, SH | 1 |
| Gershon, S | 1 |
| Bowen, DM | 1 |
| Sims, NR | 1 |
| Benton, JS | 1 |
| Curzon, G | 2 |
| Davison, AN | 1 |
| Neary, D | 1 |
| Thomas, DJ | 1 |
| Strittmatter, M | 2 |
| Hamann, GF | 2 |
| Strubel, D | 1 |
| Cramer, H | 2 |
| Schimrigk, K | 2 |
| Nagaoka, S | 1 |
| Arai, H | 1 |
| Iwamoto, N | 1 |
| Ohwada, J | 1 |
| Ichimiya, Y | 1 |
| Nakamura, M | 1 |
| Inoue, R | 1 |
| Grauer, MT | 1 |
| Antkiewicz-Michaluk, L | 1 |
| Krygowska-Wajs, A | 1 |
| Szczudlik, A | 1 |
| Romańska, I | 1 |
| Vetulani, J | 1 |
| Muenter, MD | 1 |
| Forno, LS | 1 |
| Hornykiewicz, O | 2 |
| Kish, SJ | 2 |
| Maraganore, DM | 1 |
| Caselli, RJ | 1 |
| Okazaki, H | 1 |
| Howard, FM | 1 |
| Snow, BJ | 1 |
| Calne, DB | 1 |
| Wada, H | 1 |
| Piggott, MA | 1 |
| Marshall, EF | 1 |
| Thomas, N | 1 |
| Lloyd, S | 1 |
| Court, JA | 1 |
| Jaros, E | 1 |
| Burn, D | 1 |
| Johnson, M | 1 |
| Perry, RH | 2 |
| McKeith, IG | 1 |
| Ballard, C | 1 |
| Perry, EK | 3 |
| Davies, P | 1 |
| Roos, BE | 3 |
| Meyer, JS | 1 |
| Welch, KM | 1 |
| Deshmukh, VD | 1 |
| Perez, FI | 1 |
| Jacob, RH | 1 |
| Haufrect, DB | 1 |
| Mathew, NT | 1 |
| Morrell, RM | 1 |
| Guard, O | 1 |
| Renaud, B | 1 |
| Chazot, G | 1 |
| Nazarali, AJ | 1 |
| Reynolds, GP | 1 |
| Zubenko, GS | 2 |
| Moossy, J | 1 |
| Kopp, U | 1 |
| Degrell, I | 2 |
| Nagy, E | 2 |
| Lee, S | 1 |
| Chiba, T | 1 |
| Kitahama, T | 1 |
| Kaieda, R | 1 |
| Hagiwara, M | 1 |
| Nagazumi, A | 1 |
| Terashi, A | 1 |
| Marshall, E | 2 |
| Kerwin, J | 2 |
| Smith, CJ | 1 |
| Jabeen, S | 2 |
| Cheng, AV | 1 |
| McKeith, I | 1 |
| Thompson, P | 1 |
| Edwardson, JA | 1 |
| Ince, P | 1 |
| Blessed, G | 1 |
| Irving, D | 1 |
| Tyrrell, PJ | 1 |
| Sawle, GV | 1 |
| Ibanez, V | 1 |
| Bloomfield, PM | 1 |
| Leenders, KL | 1 |
| Frackowiak, RS | 1 |
| Rossor, MN | 1 |
| Zoghbi, HY | 1 |
| Percy, AK | 1 |
| Glaze, DG | 1 |
| Butler, IJ | 1 |
| Riccardi, VM | 1 |
| Chang, LJ | 1 |
| Mirchandani, L | 1 |
| Shannak, K | 1 |
| Pék, G | 1 |
| Nagy, D | 1 |
| Hoyer, S | 1 |
| Kawakami, M | 1 |
| Itoh, T | 1 |
| Jolkkonen, J | 1 |
| Halonen, T | 1 |
| Ylinen, A | 1 |
| Laulumaa, V | 1 |
| Laakso, M | 1 |
| Riekkinen, P | 1 |
| Gjerris, A | 1 |
| Werdelin, L | 1 |
| Gjerris, F | 1 |
| Sørensen, PS | 1 |
| Rafaelsen, OJ | 1 |
| Alling, C | 1 |
| Schapiro, MB | 1 |
| Kay, AD | 2 |
| May, C | 2 |
| Ryker, AK | 1 |
| Haxby, JV | 1 |
| Kaufman, S | 2 |
| Milstien, S | 2 |
| Rapoport, SI | 1 |
| Kaye, JA | 1 |
| Daly, E | 1 |
| Atack, JR | 1 |
| Sweeney, DJ | 1 |
| Luxenberg, JS | 1 |
| Friedland, RP | 1 |
| Wester, P | 1 |
| Eriksson, S | 1 |
| Forsell, A | 1 |
| Puu, G | 1 |
| Karlsson, I | 1 |
| Bråne, G | 1 |
| Melin, E | 1 |
| Nyth, AL | 1 |
| Rybo, E | 1 |
| Mizuno, Y | 1 |
| Shimabukuro, T | 1 |
| Fukuzawa, N | 1 |
| Stahl, SM | 1 |
| Thiemann, S | 1 |
| Faull, KF | 1 |
| Barchas, JD | 1 |
| Marquis, JK | 1 |
| Nixon, RA | 1 |
| Itoh, H | 1 |
| Akiguchi, I | 1 |
| Kameyama, M | 1 |
| Cash, R | 1 |
| Dennis, T | 1 |
| L'Heureux, R | 1 |
| Raisman, R | 1 |
| Javoy-Agid, F | 1 |
| Scatton, B | 1 |
| Portin, R | 1 |
| Rinne, UK | 1 |
| Bridge, TP | 1 |
| Kleinman, JE | 1 |
| Karoum, F | 1 |
| Wyatt, RJ | 1 |
| Burger, PC | 1 |
| Vogel, FS | 1 |
| Parkes, JD | 1 |
| Marsden, CD | 1 |
| Rees, JE | 1 |
| Kantamaneni, BD | 1 |
| Knill-Jones, R | 1 |
| Akbar, A | 1 |
| Das, S | 1 |
| Kataria, M | 1 |
| Kjällquist, A | 1 |
| Pontén, U | 1 |
| Sundbärg, G | 1 |
2 reviews available for homovanillic acid and Dementia
| Article | Year |
|---|---|
Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
Topics: Adult; Aged; Dementia; Depression; Depressive Disorder; Homovanillic Acid; Humans; Huntington Diseas | 1984 |
Senile dementia and presenile dementia.
Topics: Acetylcholinesterase; Alzheimer Disease; Arginine Vasopressin; Biopterins; Brain Chemistry; Cerebral | 1990 |
1 trial available for homovanillic acid and Dementia
| Article | Year |
|---|---|
Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.
Topics: Adult; Aged; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dementia; Female; Homovanil | 1997 |
57 other studies available for homovanillic acid and Dementia
| Article | Year |
|---|---|
Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease.
Topics: Aged; Aggression; Alzheimer Disease; Dementia; Diagnosis, Differential; Follow-Up Studies; Frontal L | 2004 |
Neurotransmitters in dementia.
Topics: Adult; Aged; Alzheimer Disease; Arginine Vasopressin; Biopterins; Central Nervous System; Cerebral C | 1984 |
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
Topics: 5-Methoxytryptamine; Adult; Aged; Aging; Alcoholism; Brain; Dementia; Dopamine; Homovanillic Acid; H | 1980 |
Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
Topics: Alzheimer Disease; Cerebral Cortex; Dementia; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacet | 1980 |
Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
Topics: Aged; Dementia; Depressive Disorder; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1981 |
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Topics: Aged; Alzheimer Disease; Butyrophenones; Dementia; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac | 1981 |
Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Dementia; Furans; Glucose; Homovanillic Acid; Humans; Hydroxyi | 1982 |
Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?
Topics: Age Factors; Aged; Aging; Alzheimer Disease; Brain Chemistry; Dementia; Female; gamma-Aminobutyric A | 1982 |
Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Topics: Aged; Alcohol Amnestic Disorder; Alzheimer Disease; Dementia; Female; Homovanillic Acid; Humans; Hyd | 1982 |
Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems.
Topics: Aged; Alzheimer Disease; Blood Chemical Analysis; Cardiovascular Diseases; Dementia; Diagnosis, Diff | 1984 |
Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
Topics: Acetylcholinesterase; Adult; Aged; Aging; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dem | 1983 |
Striatal dopamine receptors in Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Choline O-Acetyltransferase; Dementia; Female; gamma-Aminobutyric Acid; Hom | 1984 |
Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Cognition; Dementia; Functional Laterality; Homovanil | 1984 |
Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
Topics: Aged; Alzheimer Disease; Dementia; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Middl | 1984 |
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Topics: Aged; Alzheimer Disease; Blood Platelets; Cognition Disorders; Dementia; Glycols; Homovanillic Acid; | 1981 |
Treatment of Alzheimer's disease: a cautionary note.
Topics: Adult; Aged; Alzheimer Disease; Dementia; Homovanillic Acid; Humans; Male; Middle Aged | 1981 |
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
Topics: Aged; Aged, 80 and over; Aging; Biogenic Monoamines; Dementia; Female; Homovanillic Acid; Humans; Hy | 1996 |
A juvenile case of frontotemporal dementia: neurochemical and neuropathological investigations.
Topics: Adult; Biogenic Monoamines; Dementia; Dopamine; Female; Frontal Lobe; Homovanillic Acid; Humans; Hyd | 1995 |
Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations.
Topics: Aged; Biogenic Monoamines; Chromatography, High Pressure Liquid; Dementia; Female; Homovanillic Acid | 1996 |
Hereditary form of parkinsonism--dementia.
Topics: Adult; Antiparkinson Agents; Choline O-Acetyltransferase; Dementia; Dopamine; Family Health; Female; | 1998 |
Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
Topics: Aged; Aged, 80 and over; Albumins; alpha 1-Antichymotrypsin; Alzheimer Disease; Blood-Brain Barrier; | 1998 |
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Corpus Striatum; Dementia; Dopamine; Fe | 1999 |
Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; De | 1979 |
Cathecholamines in the human brain and ageing.
Topics: Aged; Aging; Alzheimer Disease; Autopsy; Brain; Dementia; Dopamine; Homovanillic Acid; Humans; Norep | 1977 |
Neurotransmitter precursor amino acids in the treatment of multi-infarct dementia and Alzheimer's disease.
Topics: 5-Hydroxytryptophan; Aged; Alzheimer Disease; Carbidopa; Dementia; Dopamine; Drug Combinations; Fema | 1977 |
Changes in the brain catecholamines in patients with dementia of Alzheimer type.
Topics: Aged; Alzheimer Disease; Brain; Catecholamines; Dementia; Dopamine; Female; Homovanillic Acid; Human | 1979 |
[Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid].
Topics: Aged; Alzheimer Disease; Brain Chemistry; Dementia; Dopamine; Female; Homovanillic Acid; Humans; Hyd | 1976 |
Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Brain Chemistry; Caudate Nucleus; Dementia; Do | 1992 |
Neurochemical correlates of major depression in primary dementia.
Topics: Brain; Choline O-Acetyltransferase; Dementia; Depression; Homovanillic Acid; Humans; Hydroxyindoleac | 1990 |
Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
Topics: Adult; Aged; Alcohol Amnestic Disorder; Ascorbic Acid; Brain; Dementia; Female; Homovanillic Acid; H | 1990 |
CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly.
Topics: Alzheimer Disease; beta-Endorphin; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1990 |
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Topics: Acetylcholine; Aged; Aged, 80 and over; Autopsy; Biogenic Amines; Choline O-Acetyltransferase; Demen | 1990 |
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Dementia; Hallucinatio | 1991 |
Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type.
Topics: Adult; Aged; Alzheimer Disease; Caudate Nucleus; Dementia; Dopamine; Homovanillic Acid; Humans; Midd | 1990 |
Reduction of biogenic amine levels in the Rett syndrome.
Topics: Adolescent; Ataxia; Autistic Disorder; Biogenic Amines; Child; Child, Preschool; Dementia; Electroen | 1985 |
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltrans | 1985 |
Dementias, psychological tests, and neurotransmitters.
Topics: Aged; Alcoholism; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Homovanillic Acid; H | 1985 |
[Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
Topics: Aged; Benzoquinones; Biogenic Amines; Cerebrovascular Disorders; Chromatography, High Pressure Liqui | 1986 |
[Neurotransmitters and degenerative diseases in the central nervous system].
Topics: Acetylcholinesterase; Aged; Aging; Brain Diseases; Dementia; Dopamine; Homovanillic Acid; Humans; Hy | 1986 |
Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
Topics: Acetylcholinesterase; Adult; Aged; Aged, 80 and over; Dementia; Female; Homovanillic Acid; Humans; M | 1986 |
CSF-amine metabolites in depression, dementia and in controls.
Topics: Biogenic Amines; Body Height; Dementia; Depressive Disorder; Homovanillic Acid; Humans; Hydrocephalu | 1987 |
Cerebrospinal fluid monoamines in Down's syndrome adults at different ages.
Topics: Adult; Age Factors; Amines; Biopterins; Catecholamines; Cognition; Dementia; Down Syndrome; Female; | 1987 |
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
Topics: Aged; Alzheimer Disease; Biopterins; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1988 |
Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters.
Topics: Acetylcholinesterase; Aged; Butyrylcholinesterase; Catecholamines; Cholinesterases; Dementia; Dopami | 1988 |
Effects of environmental stimulation on biochemical and psychological variables in dementia.
Topics: Aged; Aged, 80 and over; Cognition; Dementia; Dexamethasone; Environment; Female; Homovanillic Acid; | 1988 |
Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites.
Topics: Adult; Aged; Aged, 80 and over; Dementia; Dopamine; Female; Glycols; Homovanillic Acid; Humans; Hydr | 1988 |
Neurotransmitters in the brains of patients with dementia disorders.
Topics: Acetylcholine; Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dementia; Dopamine; Glut | 1985 |
Neurochemistry of dopamine in Huntington's dementia and normal aging.
Topics: Adult; Aged; Aging; Brain; Dementia; Dopamine; Homovanillic Acid; Humans; Huntington Disease; Male; | 1986 |
Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aged; Alzheimer Disease; Cerebrospinal Fluid P | 1986 |
[Levodopa therapy in a patient with ALS-dementia complex].
Topics: Amyotrophic Lateral Sclerosis; Dementia; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged | 1987 |
Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus.
Topics: Aged; Aged, 80 and over; Brain; Dementia; Desipramine; Dopamine; Homovanillic Acid; Humans; Locus Co | 1987 |
Predictive factors for cognitive deterioration and dementia in Parkinson's disease.
Topics: Cognition Disorders; Dementia; Electroencephalography; Homovanillic Acid; Humans; Levodopa; Parkinso | 1987 |
Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Brain Chemistry; Catecholamines; Cognition; Dementia; Dopamine | 1985 |
The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.
Topics: Adolescent; Adult; Aged; Autopsy; Brain; Brain Chemistry; Child; Child, Preschool; Dementia; Down Sy | 1973 |
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
Topics: Aged; Dementia; Dihydroxyphenylalanine; Electroencephalography; Female; Gait; Homovanillic Acid; Hum | 1974 |
[Disturbances of monoamine metabolism in organic presenile and senile dementia].
Topics: Caudate Nucleus; Corpus Striatum; Dementia; Dopamine; Globus Pallidus; Homovanillic Acid; Humans; Hy | 1974 |
Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
Topics: Affective Symptoms; Aged; Bicarbonates; Carbon Dioxide; Dementia; Female; Glycolysis; Homovanillic A | 1974 |